Controlling anal incontinence in women by performing anal exercises with biofeedback or loperamide (CAPABLe) trial: Design and methods.

dc.contributor.author

Eric Jelovsek, J

dc.contributor.author

Markland, Alayne D

dc.contributor.author

Whitehead, William E

dc.contributor.author

Barber, Matthew D

dc.contributor.author

Newman, Diane K

dc.contributor.author

Rogers, Rebecca G

dc.contributor.author

Dyer, Keisha

dc.contributor.author

Visco, Anthony

dc.contributor.author

Sung, Vivian W

dc.contributor.author

Sutkin, Gary

dc.contributor.author

Meikle, Susan F

dc.contributor.author

Gantz, Marie G

dc.contributor.author

Pelvic Floor Disorders Network

dc.coverage.spatial

United States

dc.date.accessioned

2017-08-01T13:51:43Z

dc.date.available

2017-08-01T13:51:43Z

dc.date.issued

2015-09

dc.description.abstract

The goals of this trial are to determine the efficacy and safety of two treatments for women experiencing fecal incontinence. First, we aim to compare the use of loperamide to placebo and second, to compare the use of anal sphincter exercises with biofeedback to usual care. The primary outcome is the change from baseline in the St. Mark's (Vaizey) Score 24weeks after treatment initiation. As a Pelvic Floor Disorders Network (PFDN) trial, subjects are enrolling from eight PFDN clinical centers across the United States. A centralized data coordinating center supervises data collection and analysis. These two first-line treatments for fecal incontinence are being investigated simultaneously using a two-by-two randomized factorial design: a medication intervention (loperamide versus placebo) and a pelvic floor strength and sensory training intervention (anal sphincter exercises with manometry-assisted biofeedback versus usual care using an educational pamphlet). Interventionists providing the anal sphincter exercise training with biofeedback have received standardized training and assessment. Symptom severity, diary, standardized anorectal manometry and health-related quality of life outcomes are assessed using validated instruments administered by researchers masked to randomized interventions. Cost effectiveness analyses will be performed using prospectively collected data on care costs and resource utilization. This article describes the rationale and design of this randomized trial, focusing on specific research concepts of interest to researchers in the field of female pelvic floor disorders and all other providers who care for patients with fecal incontinence.

dc.identifier

https://www.ncbi.nlm.nih.gov/pubmed/26291917

dc.identifier

S1551-7144(15)30067-7

dc.identifier.eissn

1559-2030

dc.identifier.uri

https://hdl.handle.net/10161/15137

dc.language

eng

dc.publisher

Elsevier BV

dc.relation.ispartof

Contemp Clin Trials

dc.relation.isversionof

10.1016/j.cct.2015.08.009

dc.subject

Anal sphincter exercises

dc.subject

Factorial design

dc.subject

Fecal incontinence

dc.subject

Loperamide

dc.subject

Manometry-assisted biofeedback

dc.subject

Randomized placebo controlled trial

dc.title

Controlling anal incontinence in women by performing anal exercises with biofeedback or loperamide (CAPABLe) trial: Design and methods.

dc.type

Journal article

pubs.author-url

https://www.ncbi.nlm.nih.gov/pubmed/26291917

pubs.begin-page

164

pubs.end-page

174

pubs.organisational-group

Clinical Science Departments

pubs.organisational-group

Duke

pubs.organisational-group

Obstetrics and Gynecology

pubs.organisational-group

Obstetrics and Gynecology, Urogynecology

pubs.organisational-group

School of Medicine

pubs.publication-status

Published

pubs.volume

44

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
CAPABLe Methods Manuscript.pdf
Size:
386.5 KB
Format:
Adobe Portable Document Format
Description:
Published version